Evidence map›Paper›PMID 26158745›Full record

ArticleNature communications2015

Growth-regulating Mycobacterium tuberculosis VapC-mt4 toxin is an isoacceptor-specific tRNase.

Jonathan W Cruz, Jared D Sharp, Eric D Hoffer, Tatsuya Maehigashi, Irina O Vvedenskaya, Arvind Konkimalla, Robert N Husson, Bryce E Nickels, Christine M Dunham, Nancy A Woychik

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Structural mechanism of SAM-AMP and SAM-AMPNature communications · 2026
    Article
  3. Article
  4. Article
  5. Structure and mechanism of antiphage retron Eco2.Nature structural & molecular biology · 2026
    Article
  6. Review
  7. Specificity and mechanism of tRNA cleavage by the AriB Toprim nuclease of the PARIS bacterial immune system.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Identification of Genes Encoded Toxin-Antitoxin System inInfectious disorders drug targets · 2024
    Article
  19. Are all VapC toxins ofJournal of biosciences · 2024
    Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jonathan W CruzDepartment of Biochemistry and Molecular Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
Jared D SharpDivision of Infectious Diseases, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Eric D HofferDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Tatsuya MaehigashiDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Irina O Vvedenskaya1] Waksman Institute, Rutgers University, Piscataway, New Jersey 08854, USA [2] Department of Genetics, Rutgers University, Piscataway, New Jersey 08854, USA.
Arvind KonkimallaDepartment of Biochemistry and Molecular Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
Robert N HussonDivision of Infectious Diseases, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Bryce E Nickels1] Waksman Institute, Rutgers University, Piscataway, New Jersey 08854, USA [2] Department of Genetics, Rutgers University, Piscataway, New Jersey 08854, USA [3] Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08901, USA.
Christine M DunhamDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Nancy A Woychik1] Department of Biochemistry and Molecular Biology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA [2] Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08901, USA.
Rutgers, The State University of New Jersey · USEmory University · USHarvard University · USRutgers Cancer Institute of New Jersey

Funding

Structural Studies of Ribosome RegulationR01GM093278 · NIGMS · EMORY UNIVERSITY · PI DUNHAM, CHRISTINE M · 2010 to 2022
$4.6M
VIRUS-HOST INTERACTIONS IN EUKARYOTIC CELLST32AI007403 · NIAID · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI BREWER, GARY A. · 1991 to 2014
$1.7M
In Vivo Studies of Abortive InitiationR01GM088343 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI NICKELS, BRYCE EDWARD · 2011 to 2015
$1.7M
Membrane Protein Production Using the Yeast SPP SystemR01GM095693 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI WOYCHIK, NANCY ANN · 2010 to 2013
$1.3M
Functional Dissection of Toxin-Antitoxin Systems in Mycobacterium tuberculosisR21AI072399 · NIAID · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI WOYCHIK, NANCY ANN · 2009 to 2010
$463k
Stress-potentiated screening to identify novel inhibitors of M. tuberculosisR21AI097881 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI HUSSON, ROBERT N · 2012 to 2013
$451k
NIAID NIH HHS R21 AI072399NIAID NIH HHS R21 AI097881NIAID NIH HHS T32 AI007403NIGMS NIH HHS R01 GM088343NIGMS NIH HHS R01 GM093278NIGMS NIH HHS R01 GM095693
6 · The paper itself

Abstract

Toxin-antitoxin (TA) systems are implicated in the downregulation of bacterial cell growth associated with stress survival and latent tuberculosis infection, yet the activities and intracellular targets of these TA toxins are largely uncharacterized. Here, we use a specialized RNA-seq approach to identify targets of a Mycobacterium tuberculosis VapC TA toxin, VapC-mt4 (also known as VapC4), which have eluded detection using conventional approaches. Distinct from the one other characterized VapC toxin in M. tuberculosis that cuts 23S rRNA at the sarcin-ricin loop, VapC-mt4 selectively targets three of the 45 M. tuberculosis tRNAs (tRNA(Ala2), tRNA(Ser26) and tRNA(Ser24)) for cleavage at, or adjacent to, their anticodons, resulting in the generation of tRNA halves. While tRNA cleavage is sometimes enlisted as a bacterial host defense mechanism, VapC-mt4 instead alters specific tRNAs to inhibit translation and modulate growth. This stress-linked activity of VapC-mt4 mirrors basic features of eukaryotic tRNases that also generate tRNA halves and inhibit translation in response to stress.

Indexed as

AnticodonBacterial ProteinsBacterial ToxinsBlotting, NorthernEndoribonucleasesEscherichia coliIn Vitro TechniquesMolecular Docking SimulationMycobacterium tuberculosisRNA, Ribosomal, 23SRNA, TransferStress, PhysiologicalAnticodonBacterial ProteinsBacterial ToxinsEndoribonucleasesRNA, Ribosomal, 23SRNA, TransferRv0595c protein, Mycobacterium tuberculosis

Identifiers

PMID26158745
PMCPMC4620994
OpenAlexW805066248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.